1. Increased LAK and T cell activation in responding renal cell carcinoma patients after low dose cyclophosphamide, IL-2 andα-IFN

   • Peter Wersäll
   • Håkan Mellstedt

   Papers Pages: 69 - 77

2. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia

   • Freidoun Albertioni
   • Astrid Gruber
   • Sigurd Vitols

   Papers Pages: 79 - 86

3. Gynaecologic effects of tamoxifen

   • Dennis Yi-Shin Kuo
   • Carolyn D. Runowicz

   Papers Pages: 87 - 94

4. Adhesive receptors expressed by tumor cells and platelets: novel targets for therapeutic anti-metastatic strategies

   • Lesle Oleksowicz
   • Janice P. Dutcher

   Papers Pages: 95 - 102

5. Immunotherapy of a plasmacytoma with attenuated salmonella

   • Toby K. Eisenstein
   • Bonnie Bushnell
   • H. Francis Havas

   Papers Pages: 103 - 108

6. Assessment of proton magnetic resonance spectroscopy of blood serum as a diagnostic tool in bone marrow transplantation

   • Elisha Berman
   • J. Kapelushnik
   • Arnon Nagler

   Papers Pages: 109 - 114

7. Phase II trial of chemotherapy, external and intraluminal radiation plus surgery for oesophageal cancer

   • Jonathan J. Beitler
   • Scott Wadler
   • Barry A. Levine

   Papers Pages: 115 - 120

8. Levels of soluble interleukin-2 receptors are predictive of response in patients treated with interleukin-2 and lymphokine-activated killer cells

   • Elisabeth Paietta
   • David L. Nelson
   • Peter H. Wiernik

   Papers Pages: 121 - 124

9. Successful matched unrelated transplantation from a donor with idiopathic thrombocytopenic purpura (ITP)

   • M. Delukina
   • Y. Kapelushnik
   • A. Nagler

   Papers Pages: 125 - 127

10. Cancer chemotherapy and biological response modifyers, annual 14

    • Peter Wersall

    Book Review Pages: 129 - 129